Heart patients may ditch blood thinners after one year, major trial investigates

NCT ID NCT07398001

Not yet recruiting Disease control Sponsor: Ulsan University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether people who had a heart procedure with a drug-coated balloon can safely stop taking antiplatelet drugs after 12 months. The goal is to see if stopping reduces bleeding risks while keeping the heart protected. About 1,000 adults who have been event-free for a year will be randomly assigned to stop or continue their medication and followed for outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTIPLATELET THERAPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANTIPLATELET THERAPY DRUG COATED BALLOON PERCUTANEOUS CORONARY INTERVENTION

Contacts and locations

Locations

Kangwon National University Hospital

Chuncheon, South Korea
Korea University Ansan Hospital

Ansan, South Korea
Korea University Guro Hospital

Seoul, South Korea
Kosin University Hospital

Pusan, South Korea
Samsung Medical Center

Seoul, South Korea
Ulsan Medical Center

Ulsan, South Korea
Ulsan University Hospital

Ulsan, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.